ELAN Elanco Animal Health Inc stock chart & analysis

Conviction 26HealthcareScan · Fri, Nov 6, 2026

Elanco Animal Health Inc (ELAN) closed at $25.74 (+8.70%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 65, RS Rating 88, -8.0% from its 52-week high, +13.7% year to date. Sector: Healthcare · Pharmaceutical Preparations.

ELAN$25.74+8.70%

ResistanceSupportVol 14Insider buyInsider sellCongress buyCongress sell

Loading chart…

Elanco Animal Health IncPharmaceutical Preparationswww.elanco.com ↗

Price25.74

Change+8.70%

Gap+1.63%

Rel volume2.45×

Avg volume5.49M

Avg $ vol129.4M

SMA 2023.33

SMA 5023.13

SMA 20023.80

Price vs 50+11.24%

Price vs 200+8.11%

MA stackmixed

50/200 cross—

Supertrendup · 22.85

RSI (14)65

MACD hist0.27

MACD cross—

Stoch %K / %D88 / 77

ADX (14)17

+DI / −DI31 / 17

RSI divergence—

MACD divergence—

ATR %3.64%

ADR %3.47%

52w high27.98

52w low19.40

From 52w high-8.04%

Above 52w low+32.63%

New 52w highNo

SqueezeOff

Bollinger width15.95%

%B1.15

Donchian pos87.57%

Donchian high26.26

Donchian low22.03

AVWAP (52w high)23.35

vs AVWAP high+10.21%

AVWAP (52w low)23.70

vs AVWAP low+8.57%

OBV trendUp

Chaikin MF (20)0.03

Today vs 20d2.45×

Avg vol (14d)5.86M

Avg vol (20d)5.49M

Avg $ vol (20d)129.4M

Market cap12.86B

RS Rating88 / 99

RS 3m (vs SPY)+20.35%

RS 6m (vs SPY)+9.10%

RS line new highYes

Trend template4/8

Technical rank90.3

1 week+11.58%

1 month+14.15%

3 months+15.48%

6 months+8.79%

1 year+19.12%

YTD+13.70%

P/E-55.43

P/B1.94

P/S2.73

P/FCF45.28

EPS-0.4700

Div yield—

ROE-3.50%

ROA-1.74%

Debt/Eq0.53

Current2.09

EV/EBITDA—

Gross margin54.99%

Net margin-4.92%

Rev growth6.22%

EPS growth-168.64%

Price target30.70

Target upside19.32%

Analyst ratingBuy

Institutional122.66%

Ent. value15.89B

Revenue1.26B

Net income18M

Gross profit720M

Free cash flow284M

IndustryPharmaceutical Preparations

ExchangeNYSE

Shares out499.45M

Employees9.9K

ListedThu, Sep 20, 2018

Free float493.04M

Float %99.2%

Short interest—

Days to cover—

Short volume30.6%

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est$0.34 vs $0.27

Last surprise+25.9% beat

Setup gradeD

Conviction26 / 100

Pattern quality—

Tech rank90.3 / 100

Group rank23 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance23.87

Support21.69

Days since event—

Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

ELAN technical analysis

Trend

ELAN's moving averages are mixed — no clean uptrend or downtrend. It closed 11.2% above the 50-day ($23.13) and 8.1% above the 200-day ($23.80). ADX(14) at 17 points to a weak trend — more range than direction. It meets 4 of 8 trend-template criteria.

Momentum

RSI(14) is 65, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 88 puts its weighted 12-month performance ahead of about 88% of the US market, and its RS line is at a new high.

Volume and volatility

Volume on the latest session ran 2.4× its 20-day average. It trades about $129.4M a day on average. ATR(14) is $0.9360, 3.6% of price — its typical daily range. On-balance volume is trending up.

Key levels

The chart pattern's support is $21.69 and its resistance $23.87. The 52-week range is $19.40 to $27.98; price is 8.0% below the high and 32.6% above the low. The VWAP anchored at the 52-week high is $23.35, below price.

Performance

ELAN returned +11.6% (1 week), +14.1% (1 month), +15.5% (3 months), +8.8% (6 months), +19.1% (1 year), +13.7% (year to date).

About Elanco Animal Health Inc

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.

Pharmaceutical Preparations · Listed 2018 · 9,900 employees

Congress activity

Disclosed STOCK Act trades in ELAN · 1 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
Valerie Hoyle house · D · OR · traded 2025-09-23	Sell	$1K–$15K	2025-09-23	2025-10-10	PDF

Insider activity

SEC Form 4 transactions in ELAN · open-market 1 sell

Insider	Side	Shares	Value	Traded	Filed
Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR · Deferred Stock Units · 2026-10-30	Grant	122.59	$3K	2026-10-30	2026-11-03
VanHimbergen Robert M EVP and CFO · Deferred Stock Units · 2026-10-30	Grant	8.544	$197	2026-10-30	2026-11-03
Modi Rajeev A. SEE REMARKS · Deferred Stock Units · 2026-10-30	Grant	64.047	$1K	2026-10-30	2026-11-03
Bettington Timothy J SEE REMARKS · Common Stock · 2026-10-15	Sell	4.35K	$100K	2026-10-15	2026-10-19
Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR · Deferred Stock Units · 2026-09-04	Grant	115.385	$3K	2026-09-04	2026-09-09
VanHimbergen Robert M EVP and CFO · Deferred Stock Units · 2026-09-04	Grant	8.042	$197	2026-09-04	2026-09-09
Modi Rajeev A. SEE REMARKS · Deferred Stock Units · 2026-09-04	Grant	60.283	$1K	2026-09-04	2026-09-09
Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR · Deferred Stock Units · 2026-08-21	Grant	117.936	$3K	2026-08-21	2026-08-25
VanHimbergen Robert M EVP and CFO · Deferred Stock Units · 2026-08-21	Grant	8.219	$197	2026-08-21	2026-08-25
Modi Rajeev A. SEE REMARKS · Deferred Stock Units · 2026-08-21	Grant	61.616	$1K	2026-08-21	2026-08-25

SEC filings

EDGAR filings in ELAN · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.